Journalist
Lee Hyo-jung
hyo@ajunews.com
-
Samsung Bioepis Launches Ophthalmology Biosimilar 'Ofuviz' in Europe May 31, 2026
-
K-Bio Gains Global Attention at Major Conferences with Cancer, Obesity, and Diabetes Advances May 28, 2026
-
Social Welfare in the AI Era Must Uphold Human Dignity May 28, 2026
-
Increased Importance of Compliance and Ethical Management in Pharma Industry May 28, 2026
-
Samsung Medical Center to Build AI Surgical Robot Platform May 28, 2026
-
K-Bio Achieves $6.5 Billion in Technology Transfers in First Half of 2026 May 23, 2026
-
Vitamin Market Evolves with Functional and Convenient Products May 23, 2026
-
Over 80% of Diabetic Patients in Their 30s in South Korea Are Obese May 23, 2026
-
K-Beauty Surpasses $10 Billion Trade Surplus, Overtakes U.S. Cosmetics Market May 23, 2026
-
Kwangdong Pharmaceutical Secures Domestic Approval for Fabry Disease Treatment May 23, 2026
